In December 2023, NCRS LLC completed construction of its new laboratory complex, significantly expanding the company's capabilities in developing, certifying, and producing reference materials for active pharmaceutical ingredients (APIs) and their impurity compounds.
With the commissioning of the new facility, NCRS has begun executing commercial contracts for pharmaceutical quality control, as well as conducting research and development (R&D) projects in compliance with international standards.
The laboratory complex is equipped with cutting-edge analytical systems from global industry leaders, ensuring high precision and reproducible results. Our testing portfolio includes:
Chromatographic Analysis Methods
- High-performance liquid chromatography (HPLC)
- Gas chromatography (GC)
- Thin-layer chromatography (TLC)
Spectroscopic Analysis Methods
- Ultraviolet-Visible (UV-Vis) and Infrared (IR) spectroscopy
- Refractometry and polarimetry
Pharmacopoeial Compliance Testing
Comparative Dissolution Kinetics Testing
Bioanalytical Studies
Compliance with International Standards
In the near future, the NCRS laboratory plans to obtain ISO/IEC 17025:2017 (GOST ISO/IEC 17025-2019) accreditation ("General requirements for the competence of testing and calibration laboratories"), which will confirm compliance with the highest standards of quality and data reliability.
